Christoph Luke
Overview
Explore the profile of Christoph Luke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
350
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mackiewicz J, Maaijwee K, Luke C, Kociok N, Hiebl W, Meinert H, et al.
Graefes Arch Clin Exp Ophthalmol
. 2015 Apr;
253(6):985-6.
PMID: 25851864
No abstract available.
2.
Luke M, Januschowski K, Tura A, Luke J, Nassar K, Luke C, et al.
Curr Eye Res
. 2010 Apr;
35(3):248-54.
PMID: 20373885
Purpose: To evaluate the short-term toxic effects of pegaptanib sodium on retinal function. At present, intraocular anti-vascular endothelial growth factor (VEGF) therapy is the primary choice of treatment for neovascular...
3.
Luke M, Januschowski K, Beutel J, Warga M, Grisanti S, Peters S, et al.
Exp Eye Res
. 2008 Jun;
87(1):22-9.
PMID: 18514644
A good clinical experience of intravitreal triamcinolone acetonide (TA) has been reported in several studies, but there are growing indications that epiretinal crystals of TA exhibit retinal toxicity. To investigate...
4.
Dietlein T, Jordan J, Luke C, Schild A, Dinslage S, Krieglstein G
Acta Ophthalmol
. 2008 May;
86(8):856-9.
PMID: 18494743
Purpose: To test whether patients aged >or=80 years can safely and successfully apply eyedrops from a single-use eyedrop container without support, and to compare the results with those of younger...
5.
Luke C, Dietlein T, Luke M, Konen W, Krieglstein G
Graefes Arch Clin Exp Ophthalmol
. 2008 Apr;
246(8):1163-8.
PMID: 18414886
Background: Combined phacoemulsification, intraocular lens implantation, and trabeculectomy (PTE) is currently the standard procedure for most ophthalmic surgeons to treat uncontrolled open-angle glaucoma and cataract at one time. This study...
6.
Dietlein T, Jordan J, Schild A, Konen W, Junemann A, Luke C, et al.
J Cataract Refract Surg
. 2008 Feb;
34(2):247-52.
PMID: 18242448
Purpose: To study prospectively the safety and pressure-reducing efficacy of the Y-shaped Eyepass glaucoma implant (GMP Vision Solutions, Inc.). Setting: Departments of Ophthalmology, University of Cologne, Cologne, and University of...
7.
Luke M, Januschowski K, Beutel J, Luke C, Grisanti S, Peters S, et al.
Graefes Arch Clin Exp Ophthalmol
. 2008 Jan;
246(6):817-22.
PMID: 18197412
Background: To facilitate epiretinal or inner limiting membrane peeling dyes like Indocyanine Green (ICG) as well as Trypan Blue (TB) were used so far. However, toxic effects on the retina...
8.
Hueber A, Esser J, Kociok N, Welsandt G, Luke C, Roters S, et al.
Graefes Arch Clin Exp Ophthalmol
. 2007 Oct;
246(2):297-304.
PMID: 17934748
Background: Despite the adjuvant use of mitomycin C during trabeculectomy, failures still occur. We investigated whether cultured human Tenon fibroblasts exposed to low-dose mitomycin C developed a multidrug resistance phenotype...
9.
Mackiewicz J, Muhling B, Hiebl W, Meinert H, Maaijwee K, Kociok N, et al.
Invest Ophthalmol Vis Sci
. 2007 Mar;
48(4):1873-83.
PMID: 17389523
Purpose: Heavy silicone oils are currently under investigation as a permanent tamponade in eyes with inferior PVR. This study was an investigation of Densiron 68 (Fluoron GmbH, Neu-Ulm, Germany) and...
10.
Luke M, Januschowski K, Warga M, Beutel J, Leitritz M, Gelisken F, et al.
Br J Ophthalmol
. 2007 Mar;
91(8):1077-82.
PMID: 17383998
Aim: To investigate the retinal toxicity of bevacizumab in co-application with a commercially available recombinant tissue plasminogen activator (rt-PA), and to facilitate a new therapeutic concept in the treatment of...